Managed Care Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Fundacion Instituto de Inmunologia de Colombia
Research in malaria vaccines provides new insights
October 9th, 2005
Reports from Colombia and the United States highlight recent research on malaria vaccines. Study 1: Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against Plasmodium vivax in Aotus monkeys. "Effector mechanisms responsible for providing protective immunity against Plasmodium vivax (Pv) infection were examined in Aotus monkeys vaccinated with two Pv merozoite surface protein-1 (PvMSP-1) recombinant polypeptides that had previously been shown to protect vaccines against parasite challenge," scientists in Colombia report. ...
Source: Managed Care Law Weekly (2005-10-09)
|
